GLP-1 injection side effects Weekly injections like Wegovy and Zepbound can cause injection site reactions such as redness, itching, or mild swelling
Interestingly, this residue is conserved in Class B1 GPCRs, such as glucagon, vasoactive intestinal peptide (VIP), and glucagon-like peptide-1 (GLP-1) (Liu et al., 2025)
The treatment doubled the relapse-free period
In un altro studio di 52 settimane su 1.748 pazienti diabetici di tipo 2, il trattamento con semaglutide (0,5 mg o 1 mg una volta alla settimana) ha ridotto il peso corporeo medio rispetto al basale di 4,1 kg 4
Fosgerau, K
This means that hiccups have not been identified as occurring with sufficient frequency or clear causality to warrant inclusion in the formal safety profile of semaglutide